FM
RPTP

Forward Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Forward Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-165,500
Closed -$1.71M – 405
2015
Q1 		$1.71M Buy
+165,500
New +$1.69M 0.1% 119

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Forward Management's RPTP Position: Q2 2015 in Review

Forward Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2015, closing a stake of 165,500 shares — an estimated $1.71M sold.

Forward Management first reported a position in RPTP in Q1 2015 and held it in 1 quarter. The position peaked at $1.71M in Q1 2015. 100 funds tracked by Wall St. Rank hold RPTP as of Q2 2015.

  • Forward Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Forward Management sold 165,500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2015, an estimated $1.71M.
  • Forward Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Forward Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.71M in Q1 2015.
  • 100 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2015.

Based on Forward Management's 13F filing for Q2 2015, filed 11 Aug 2015.